Artwork

Content provided by Clinical Care Options, LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options, LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges

25:05
 
Share
 

Manage episode 359930868 series 3256997
Content provided by Clinical Care Options, LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options, LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, Banu Arun, MD; Allison Butts, PharmD, BCOP; and Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP, discuss the role of BRCA testing and adjuvant olaparib in early breast cancer, including their experiences and challenges with implementing recent data. This overview will include discussion of:

  • Data supporting the use of adjuvant PARP inhibition in early breast cancer and impact on BRCA testing and clinical practice
  • The multidisciplinary role in ensuring that BRCA testing is completed for eligible patients
  • Barriers to implementing BRCA testing and adjuvant olaparib in clinical practice and methods to overcome them
  • Administration of adjuvant olaparib with other available adjuvant systemic therapies
  • Tolerability of single-agent PARP inhibitors

Presenters:

Banu Arun, MD
Professor, Breast Medical Oncology
Director, Clinical Cancer Genetics

University of Texas MD Anderson Cancer Center

Houston, Texas

Allison Butts, PharmD, BCOP
Pharmacist Manager, Oncology
Director, PGY2 Oncology Residency Program

UK HealthCare

Assistant Adjunct Professor

UK College of Pharmacy

Lexington, Kentucky

Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP
Nurse Practitioner
Breast Oncology

Texas Oncology Baylor Sammons Cancer Center

Dallas, Texas

Content supported by educational grants from AstraZeneca and Merck Sharp & Dohme Corp.

Link to full program:
https://bit.ly/42VeUMM

  continue reading

194 episodes

Artwork
iconShare
 
Manage episode 359930868 series 3256997
Content provided by Clinical Care Options, LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options, LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, Banu Arun, MD; Allison Butts, PharmD, BCOP; and Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP, discuss the role of BRCA testing and adjuvant olaparib in early breast cancer, including their experiences and challenges with implementing recent data. This overview will include discussion of:

  • Data supporting the use of adjuvant PARP inhibition in early breast cancer and impact on BRCA testing and clinical practice
  • The multidisciplinary role in ensuring that BRCA testing is completed for eligible patients
  • Barriers to implementing BRCA testing and adjuvant olaparib in clinical practice and methods to overcome them
  • Administration of adjuvant olaparib with other available adjuvant systemic therapies
  • Tolerability of single-agent PARP inhibitors

Presenters:

Banu Arun, MD
Professor, Breast Medical Oncology
Director, Clinical Cancer Genetics

University of Texas MD Anderson Cancer Center

Houston, Texas

Allison Butts, PharmD, BCOP
Pharmacist Manager, Oncology
Director, PGY2 Oncology Residency Program

UK HealthCare

Assistant Adjunct Professor

UK College of Pharmacy

Lexington, Kentucky

Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP
Nurse Practitioner
Breast Oncology

Texas Oncology Baylor Sammons Cancer Center

Dallas, Texas

Content supported by educational grants from AstraZeneca and Merck Sharp & Dohme Corp.

Link to full program:
https://bit.ly/42VeUMM

  continue reading

194 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play